benzofurans and Osteomyelitis

benzofurans has been researched along with Osteomyelitis* in 2 studies

Trials

2 trial(s) available for benzofurans and Osteomyelitis

ArticleYear
Bone and Joint Tissue Penetration of the
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:3

    Afabicin (formerly Debio 1450, AFN-1720) is a prodrug of afabicin desphosphono (Debio 1452, AFN-1252), a novel antibiotic in development which targets the staphylococcal enoyl-acyl carrier protein reductase (FabI) and exhibits selective potent antibacterial activity against staphylococcal species, including methicillin-resistant

    Topics: Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Benzofurans; Bone and Bones; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Naphthyridines; Osteomyelitis; Prosthesis-Related Infections; Pyrones; Staphylococcal Infections

2019
[Studies on the problem of the possible use of aristolochic acid in chronic inflammatory processes of the jaw region. Preliminary report].
    DDZ. das Deutsche Zahnarzteblatt, 1968, Volume: 22, Issue:2

    Topics: Anti-Inflammatory Agents; Benzofurans; Humans; Jaw Diseases; Jaw Neoplasms; Odontogenic Cysts; Osteomyelitis; Stomatitis

1968